DPIIT recognised startup Government of India
Startup India
Pharmacoevidence Private Limited - business outsourcing in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹44.55 Cr
▲ 33% YoY
Net profit · FY 2025
₹15.84 Cr
Net margin 35.6%
EBITDA · FY 2025
₹21.5 Cr
EBITDA margin 48.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Pharmacoevidence Private Limited
Data last updated:
Pharmacoevidence Private Limited is a private limited company based in Mohali, Punjab, India, recognised as a startup by DPIIT. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 21 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U72100PB2020PTC051449. Its GSTIN is 03AALCP2665C1ZN (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gagandeep Kaur and Barinder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 302 Second Floor Phase 8A Industrial Area, Mohali, Punjab, India – 160071.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.55 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹15.84 Cr (net margin 35.6%) and EBITDA of ₹21.5 Cr (EBITDA margin 48.3%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
Pharmacoevidence Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-20-0000607). For more details, the company can be reached via its website pharmacoevidence.com.
Company details
CIN U72100PB2020PTC051449
Registration Number 051449
Incorporation Date 21 July 2020
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification MSME
Udyam Registration UDYAM-PB-20-0000607
CIN history
Pharmacoevidence has one previous CIN (Corporate Identification Number): U73100PB2020PTC051449. The current CIN is U72100PB2020PTC051449, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72100PB2020PTC051449 | Current |
| U73100PB2020PTC051449 | Previous |
Key People
Gagandeep Kaur Director Barinder Singh Director Recognitions & Rankings of Pharmacoevidence
MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-PB-20-0000607
Contact details
Pharmacoevidence Private Limited's registered office is in Mohali, Punjab. Its website is pharmacoevidence.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 302 Second Floor Phase 8A Industrial Area, Mohali, Punjab, India – 160071
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Pharmacoevidence Private Limited, buy the company report.
Comprehensive company report
Pharmacoevidence Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pharmacoevidence is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Pharmacoevidence Private Limited, buy the company report.
Financials of Pharmacoevidence Private Limited
FY 2025 filings availablePharmacoevidence Private Limited reported revenue of ₹44.55 Cr (up 33% YoY) for FY 2025.
Revenue · FY 2025
₹44.55 Cr ▲ 33%
Net profit · FY 2025
₹15.84 Cr margin 35.6%
EBITDA · FY 2025
₹21.5 Cr margin 48.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 45%
3 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 52% over three years, including 33% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹44.55 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 48.3% | ||||
| Net Profit Margin | 35.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmacoevidence Private Limited, buy the company report.
Board of directors of Pharmacoevidence Private Limited
Pharmacoevidence has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gagandeep Kaur | Director | 01 Jun 2021 | 5 Years 4 Months | Current |
| Barinder Singh Also directs: Heorlytics Private Limited | Director | 21 Jul 2020 | 6 Years 3 Months | Current |
Auditor
Pharmacoevidence Private Limited is audited by VICKY KAPOOR for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VICKY KAPOOR | FY 2024 | 548499 |
Shareholding
The shareholding of Pharmacoevidence Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pharmacoevidence Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmacoevidence Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmacoevidence Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmacoevidence Private Limited has 1 active EPFO establishment as of Feb 22, 2026.
Active EPFO establishments
1
GST
Pharmacoevidence has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AALCP2665C1ZN | Punjab | Active | 23 Jul 2020 |
To see the full GST registrations and return filing status of Pharmacoevidence Private Limited, buy the company report.
Recent activity
Pharmacoevidence Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Joginder Kaur ceased to be Director on 10 Apr 2023.
AGM
Pharmacoevidence Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharmacoevidence Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Joginder Kaur ceased to be Director.
Appointed
Gagandeep Kaur was appointed as Director.
Appointed
Barinder Singh was appointed as Director.
Incorporation
21 Jul 2020
Pharmacoevidence Private Limited was registered on 21 Jul 2020 with Roc Chandigarh & aged 6 years 3 months as per MCA records.
Frequently asked questions
Pharmacoevidence is an active private limited company based in Mohali, Punjab, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 21 July 2020 (6+ years old) and is registered under CIN U72100PB2020PTC051449.
Pharmacoevidence has 2 current directors:
- Gagandeep Kaur - Director
- Barinder Singh - Director
The latest financial statements of Pharmacoevidence on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Pharmacoevidence is 03AALCP2665C1ZN, registered in Punjab.
The CIN (Corporate Identification Number) of Pharmacoevidence is U72100PB2020PTC051449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmacoevidence was incorporated on 21 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chandigarh.
Joginder Kaur ceased to be Director on 10 Apr 2023. Gagandeep Kaur was appointed as Director on 01 Jun 2021. Barinder Singh was appointed as Director on 21 Jul 2020.
Yes, Pharmacoevidence is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Pharmacoevidence is registered as an MSME under Udyam registration (number: UDYAM-PB-20-0000607).
Pharmacoevidence can be reached through the website pharmacoevidence.com. Its registered office is in Mohali, Punjab, India.